Prior Asymptomatic Intraparenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis (P6.239)

CONCLUSIONS: In comparison with the rate of symptomatic ICH reported in the NINDS trial (6.4[percnt]), patients with a history of asymptomatic intraparenchymal hemorrhage that presented with an acute ischemic stroke did not show an increased risk of developing symptomatic intracranial hemorrhage after IV thrombolysis (p<0.001).Disclosure: Dr. AbdelRazek has nothing to disclose. Dr. Mowla has nothing to disclose. Dr. Zimmer has nothing to disclose. Dr. Elsadek has nothing to disclose. Dr. Abdelhamid has nothing to disclose. Dr. Elsadek has nothing to disclose. Dr. Kavak has nothing to disclose. Dr. Farooq has nothing to disclose. Dr. Kamal has nothing to disclose. Dr. Crumlish has nothing to disclose. Dr. Shirani has nothing to disclose. Dr. Sawyer has nothing to disclose.

Source: Neurology - April 8, 2015 Category: Neurology Authors: AbdelRazek, M., Mowla, A., Zimmer, W., Elsadek, R., Abdelhamid, N., Elsadek, L., Kavak, K., Farooq, S., Kamal, H., Crumlish, A., Shirani, P., Sawyer, R. Tags: Cerebrovascular Disease and Interventional Neurology: Thrombolysis Complications Source Type: research